4//SEC Filing
Schick Michael E 4
Accession 0001127602-11-029990
CIK 0001097264other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:05 PM ET
Size
6.7 KB
Accession
0001127602-11-029990
Insider Transaction Report
Form 4
Schick Michael E
VP, Sales and Marketing
Transactions
- Sale
Common Stock
2011-11-16$1.43/sh−140$201→ 159,764 total - Sale
Common Stock
2011-11-15$1.44/sh−8,033$11,576→ 159,904 total
Footnotes (2)
- [F1]These shares are being sold pursuant to a 10b5-1 plan for Michael E. Schick in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on October 20, 2011. The delivery of shares was delayed until November 14, 2011, due to legal / regulatory restrictions applicable to the Company.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.43 to $1.47. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001500560
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 5:05 PM ET
- Size
- 6.7 KB